An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer

Overview of attention for article published in PLOS ONE, January 2012

Altmetric Badge

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 57 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Fused heteroaryl diamide compounds useful as MMP-13 inhibitors

Grant US-8338367-B2

United States of America

Fused Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors

Application US-20110269668-A1

United States of America